Literature DB >> 4657650

[The therapeutic effect of L-dopa].

P Groneberg, A Struppler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4657650     DOI: 10.1007/bf00609813

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


× No keyword cloud information.
  35 in total

1.  INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM.

Authors:  L J POIRIER; T L SOURKES
Journal:  Brain       Date:  1965-03       Impact factor: 13.501

2.  L-dopa in depressed patients.

Authors:  W E Bunney; D L Murphy; H K Brodie; F K Goodwin
Journal:  Lancet       Date:  1970-02-14       Impact factor: 79.321

3.  Effect of L-DOPA on depression.

Authors:  W E Bunney; D S Janowsky; F K Goodwin; J M Davis; H K Brodie; D L Murphy; T N Chase
Journal:  Lancet       Date:  1969-04-26       Impact factor: 79.321

4.  [Experimental results of the combined treatment of parkinsonism using L-DOPA and a decarboxylase inhibitory agent (Ro 4-4602)].

Authors:  W Birkmayer
Journal:  Wien Klin Wochenschr       Date:  1969-09-26       Impact factor: 1.704

5.  Functional role of the nigro-neostriatal dopamine neurons.

Authors:  N E Andén; A Dahlström; K Fuxe; K Larsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1966

6.  [Effect of the combined treatment of Parkinson patients with L-Dopa and a decarboxylase inhibitor (Ro4-4602). Quantitative analysis of bradykinesia by means of reaction time measurements].

Authors:  W Kaufmann; P Butz; M Wiesendanger
Journal:  Dtsch Z Nervenheilkd       Date:  1970

7.  [Current therapeutic problems of the parkinson syndrome].

Authors:  G W Völler; W Kapp
Journal:  Med Welt       Date:  1971-08-21

8.  The nigrostriatal pathway: a correlative study based on neuroanatomical and neurochemical criteria in the cat and the monkey.

Authors:  P Bédard; L Larochelle; A Parent; L J Poirier
Journal:  Exp Neurol       Date:  1969-11       Impact factor: 5.330

9.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

10.  [A contribution to the biochemical treatment of the akinetic type of the Parkinson's syndrome].

Authors:  G W Völler
Journal:  Med Welt       Date:  1968-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.